Drug Profile
Melanin
Latest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Large Scale Biology Corporation (CEASED)
- Developer Large Scale Biology Corporation (CEASED); SRI International
- Class Anti-inflammatories
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 11 Feb 2003 Discontinued - Preclinical for Inflammation in USA (unspecified route)
- 16 Nov 1999 Biosource Technologies is now called Large Scale Biology Corporation
- 22 May 1997 New profile